
News|Podcasts|August 20, 2025
The Weekly Dose: Nutrition Gaps, Tau Pathology in Mood Disorders, RSV Protection, and More
Author(s)Sydney Jennings
Fact checked by: Grace Halsey
This week’s roundup covers nutrition counseling barriers, tau pathology in mood disorders, RSV protection, AD patient needs, and a new Shingrix syringe.
Advertisement
Welcome to this week’s comprehensive breakdown of The Weekly Dose, your essential source for the latest updates in medicine and clinical care. This episode covers a diverse range of topics—from nutrition counseling and neurodegenerative research to breakthrough RSV prevention, patient-centered dermatology, and vaccine delivery innovations. Above, we’ll dive deep into each story, unpacking the nuances, expert insights, and actionable recommendations that clinicians can apply in their practice.
EPISODE BREAKDOWN
Editor's note: Episode timestamps produced using AI tools.
- Nutrition Counseling Insights (00:00:11): Global survey of clinicians on diet recommendations, barriers to counseling, and concerns about fad diets and food safety.
- Neurodegenerative Pathologies in Mood Disorders (00:01:26): Research on Alzheimer’s and non-Alzheimer’s tau pathologies in late-life depression and bipolar disorder, emphasizing diagnostic implications.
- RSV Prevention in Infants (00:01:26): Large study on nirsevimab’s effectiveness in preventing RSV in healthy term infants, supporting current recommendations.
- Patient Priorities in Atopic Dermatitis (00:02:52): Survey on patient experiences, misdiagnosis rates, treatment goals, and interest in personalized approaches for atopic dermatitis.
- Prefilled Syringe for Shingles Vaccine (00:04:10): FDA approval of a new prefilled syringe formulation for the recombinant zoster vaccine, simplifying administration for shingles prevention.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues Complete Response Letter for Cingulate ADHD Drug CTx-1301
2
FDA Approves Xocova as First Oral COVID-19 Postexposure Prophylaxis Option
3
Pediatric Influenza Vaccination Linked to Fewer Diagnoses in Claims Study
4
Transdermal Hormone Therapy for VMS and Cardiovascular Risk Management
5

















































































































































